Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.44 |
| ▸ | DRD4 known ✓ | P21917 | 1/20 | 0.41 |
| ▸ | DDB1 known ✓ | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN known ✓ | Q96SW2 | 1/20 | 0.41 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 known ✓ | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.41 |
| ▸ | CCR5 known ✓ | P51681 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29743227 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29507637 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29743225 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL2056505 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29742299 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL60671 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29507617 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29742285 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30853689 | 0.98 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1481510 | 0.96 | ALDH1A1 (0.50) | ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008027350-A2 | ACETAMINOPHEN PHARMACEUTICAL COMPOSITIONS | AAIPHARMA INC. (US) | 2008-03-06 | — | — | WO | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-2397161-B1 | DISINTEGRATING PARTICLE COMPOSITION AND RAPIDLY DISINTEGRATING COMPRESSION-MOLDED MATERIAL COMPRISING SAME | FUJI CHEM IND CO LTD (JP) | 2019-09-25 | — | — | EP | disclosed |
| EP-1660050-B1 | Ibuprofen-containing fast dissolving tablet | WYETH LLC (US) | 2016-11-23 | — | — | EP | disclosed |
| EP-2604256-B1 | Multi layer coatings | HEXAL AG (DE) | 2016-04-13 | — | — | EP | disclosed |
| US-20140249190-A1 | Fast Dissolving Tablet | WYETH LLC (US) | 2014-09-04 | — | — | US | disclosed |
| US-20130296385-A1 | Fast Dissolving Tablet | WYETH LLC (US) | 2013-11-07 | — | — | US | disclosed |
| EP-2604256-A1 | Multi layer coatings | Hexal AG (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-8202538-B2 | Orally disintegrating layered compositions | CAPRICORN PHARMA, INC. (US) | 2012-06-19 | — | — | US | disclosed |
| US-20120082721-A1 | Enteric coating | H E X A L AKTIENGESELLSCHAFT (DE) | 2012-04-05 | — | — | US | disclosed |
| US-20120040001-A1 | DISINTEGRATING PARTICLE COMPOSITION AND RAPIDLY DISINTEGRATING COMPRESSION-MOLDED MATERIAL USED THE SAME | FUJI CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-16 | — | — | US | disclosed |
| EP-1101490-A1 | PREPARATION CAPABLE OF RELEASING DRUG AT TARGET SITE IN INTESTINE | TANABE SEIYAKU CO., LTD. (JP) | 2001-05-23 | — | — | EP | disclosed |
| EP-1008353-A1 | SACCHARIDE-CONTAINING COMPOSITIONS | FUJI CHEMICAL INDUSTRY CO., LTD. (JP) | 2000-06-14 | — | — | EP | disclosed |
| US-5837285-A | COMPRESSED, SHAPED; XYLITOL AND LACTOSE OR MANNITOL; INFANTS, ELDERLY; STABILITY; CHEMICAL RESISTANCE | NIPPON SHINYAKU CO., LTD. (JP) | 1998-11-17 | — | — | US | disclosed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| EP-0665010-A1 | METHOD OF MANUFACTURING WAX MATRICES | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1995-08-02 | — | — | EP | disclosed |
| EP-0497977-B1 | GASTRIC PREPARATION | NIPPON SHINYAKU CO LTD (JP) | 1995-03-15 | — | — | EP | disclosed |
| EP-0627218-A1 | FAST SOLUBLE TABLET | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1994-12-07 | — | — | EP | disclosed |
| US-5368861-A | Gastric preparation with sustained release | NIPPON SHINYAKU CO., LTD. (JP) | 1994-11-29 | — | — | US | disclosed |
| EP-0497977-A1 | GASTRIC PREPARATION | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1992-08-12 | — | — | EP | disclosed |